Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership190,650 shares
Latest Disclosed Value $ 10,745,034
D. E. Shaw & Co., Inc. reports 45.01% increase in ownership of HAE / Haemonetics Corporation

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 190,650 shares of Haemonetics Corporation (US:HAE) valued at $10,745,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 131,477 shares of Haemonetics Corporation. This represents a change in shares of 45.01% during the quarter. The current value of the position is $12,560,022 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 190,650 59,173 45.01 10,745 1.97 0.0065
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 131,477 131,477 10,538 0.0058
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -18,237 -100.00 0 -100.00
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 18,237 18,237 1,424 0.0010
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -140,264 -100.00 0 -100.00
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 140,264 104,849 296.06 11,604 283.98 0.0109
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 35,415 7,160 25.34 3,023 25.08 0.0026
2024-02-14 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 28,255 -1,153 -3.92 2,416 -8.28 0.0021
2023-11-14 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 29,408 1,651 5.95 2,634 11.47 0.0028
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 27,757 -82 -0.29 2,363 2.61 0.0024
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 27,839 27,839 2,304 0.0025
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 0 -7,998 -100.00 0 -100.00
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 7,998 -32,820 -80.41 592 -77.75 0.0007
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 40,818 -133,304 -76.56 2,661 -75.83 0.0031
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 174,122 -16,589 -8.70 11,008 8.83 0.0103
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 190,711 -68,911 -26.54 10,115 -44.81 0.0084
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 259,622 -256,145 -49.66 18,327 -46.68 0.0165
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 515,767 399,381 343.15 34,371 166.03 0.0297
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 116,386 79,166 212.70 12,920 192.31 0.0125
2021-02-16 2020-12-31 13F HAEMONETICS COM 405024100 37,220 -207,222 -84.77 4,420 -79.28 0.0040
2020-11-16 2020-09-30 13F HAEMONETICS COM 405024100 244,442 129,566 112.79 21,327 107.30 0.0218
2020-08-14 2020-06-30 13F HAEMONETICS COM 405024100 114,876 15,591 15.70 10,288 3.97 0.0123
2020-05-15 2020-03-31 13F HAEMONETICS COM 405024100 99,285 -3,089 -3.02 9,895 -15.88 0.0154
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 102,374 74,825 271.61 11,763 238.50 0.0135
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 27,549 -59,303 -68.28 3,475 -66.75 0.0043
2019-08-14 2019-06-30 13F HAEMONETICS COM 405024100 86,852 -183,756 -67.90 10,452 -55.85 0.0130
2019-05-15 2019-03-31 13F HAEMONETICS COM 405024100 270,608 31,037 12.96 23,673 -1.23 0.0306
2019-02-14 2018-12-31 13F HAEMONETICS COM 405024100 239,571 -87,525 -26.76 23,969 -36.05 0.0330
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 327,096 -70,225 -17.67 37,478 5.18 0.0450
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 397,321 346,415 680.50 35,632 856.82 0.0465
2018-05-15 2018-03-31 13F HAEMONETICS COM 405024100 50,906 30,398 148.23 3,724 212.68 0.0051
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 20,508 -88,930 -81.26 1,191 -75.74 0.0016
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 109,438 18,186 19.93 4,910 36.24 0.0075
2017-08-14 2017-06-30 13F HAEMONETICS COM 405024100 91,252 39,310 75.68 3,604 71.05 0.0060
2017-05-15 2017-03-31 13F HAEMONETICS COM 405024100 51,942 -4,716 -8.32 2,107 -7.51 0.0037
2017-02-14 2016-12-31 13F HAEMONETICS COM 405024100 56,658 -62,480 -52.44 2,278 -47.20 0.0039
2016-11-14 2016-09-30 13F HAEMONETICS COM 405024100 119,138 -38,766 -24.55 4,314 -5.77 0.0076
2016-08-15 2016-06-30 13F HAEMONETICS COM 405024100 157,904 92,912 142.96 4,578 101.41 0.0084
2016-05-16 2016-03-31 13F HAEMONETICS COM 405024100 64,992 52,460 418.61 2,273 462.62 0.0041
2016-02-16 2015-12-31 13F HAEMONETICS COM 405024100 12,532 -40,624 -76.42 404 -76.48 0.0006
2015-11-16 2015-09-30 13F HAEMONETICS COM 405024100 53,156 39,805 298.14 1,718 294.94 0.0025
2014-05-15 2014-03-31 13F HAEMONETICS COM 405024100 13,351 13,351 33.48 435 9.02 0.0006
2014-02-14 2013-12-31 13F HAEMONETICS COM 405024100 0 -10,002 -100.00 0 -100.00
2013-11-20 2013-09-30 13F/A-1 HAEMONETICS COM 405024100 10,002 -75,672 -88.33 399 -88.74 0.0006
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 10,002 399
2013-08-14 2013-06-30 13F HAEMONETICS COM 405024100 85,674 85,674 3,543 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.